Startup India Government of India
Anekant Pharmaceuticals Private Limited - pharma in Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2021
₹29.83 Cr
▲ 54% YoY
Net profit · FY 2021
₹7.13 Lakh
Net margin 0.2%
EBITDA · FY 2021
₹10.76 Lakh
EBITDA margin 0.4%
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹5.5 Lakh
Issued & subscribed
Open charges
₹1.1 Cr
Secured borrowings
Company age
9 yrs
Est. 2017
Directors on board
5
As per MCA filings
About Anekant Pharmaceuticals Private Limited
Data last updated:
Anekant Pharmaceuticals Private Limited is a private limited company based in Delhi, India, recognised as a startup by DPIIT. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 06 February 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U36100DL2017PTC311457. Its GSTIN is 09AAYCS1829C1ZZ (Uttar Pradesh).
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹5.5 Lakh. It was formerly known as Seramejor Technologies Private Limited and Invent Pharma Agencies Private Limited. It is led by directors including Jai Krishan Aggarwal and Motilal Chawla.
Its last annual general meeting (AGM) was held on 30 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office is at B – 399 Nirman Vihar, Delhi, India – 110092.
As per the financials filed for FY 2021, the company reported a revenue of ₹29.83 Cr, a growth of 54% compared to the previous year. For the same year it recorded a net profit of ₹7.13 Lakh (net margin 0.2%) and EBITDA of ₹10.76 Lakh (EBITDA margin 0.4%).
As per MCA filings, the company has open charges of ₹1.1 Cr on record. Court records list 1 case involving the company, including 1 filed against it; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website anekantpharma.com.
Company details
CIN U36100DL2017PTC311457
Registration Number 311457
Incorporation Date 06 February 2017
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 November 2021
Date of Balance Sheet 31 March 2021
Compliance Status Active Compliant
DPIIT Recognition Recognised Startup
Name history
Anekant Pharmaceuticals has undergone 2 name changes throughout its history. The company was previously known as Seramejor Technologies Private Limited, and Invent Pharma Agencies Private Limited. The current legal name is Anekant Pharmaceuticals Private Limited.
| Company Name | Status |
|---|---|
| Anekant Pharmaceuticals Private Limited | Current |
| Seramejor Technologies Private Limited | Previous |
| Invent Pharma Agencies Private Limited | Previous |
CIN history
Anekant Pharmaceuticals has one previous CIN (Corporate Identification Number): U74999DL2017PTC311457. The current CIN is U36100DL2017PTC311457, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U36100DL2017PTC311457 | Current |
| U74999DL2017PTC311457 | Previous |
Recognitions & Rankings of Anekant Pharmaceuticals
Contact details
Anekant Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its website is anekantpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressB – 399 Nirman Vihar, Delhi, India – 110092
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Anekant Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Anekant Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Anekant Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Anekant Pharmaceuticals Private Limited, buy the company report.
Financials of Anekant Pharmaceuticals Private Limited
FY 2021 filings availableAnekant Pharmaceuticals Private Limited reported revenue of ₹29.83 Cr (up 54% YoY) for FY 2021.
Revenue · FY 2021
₹29.83 Cr ▲ 54%
Net profit · FY 2021
₹7.13 Lakh margin 0.2%
EBITDA · FY 2021
₹10.76 Lakh margin 0.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 54%
EBITDA CAGR growth
1 year
▼ 3%
Revenue rose 54% in the latest year. EBITDA fell 3% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹29.83 Cr | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹10.76 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹7.13 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.4% | ||||
| Net Profit Margin | 0.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Anekant Pharmaceuticals Private Limited, buy the company report.
Board of directors of Anekant Pharmaceuticals Private Limited
Anekant Pharmaceuticals has 5 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jai Krishan Aggarwal Also directs: Salasar Techno Engineering Limited, Primatel Fibcom Limited | Director | 31 Jul 2020 | 6 Years 2 Months | Current |
| Pankaj Jain Also directs: Akpj Garments Private Limited, Starsun Packaging Solutions Private Limited, Axis Herbals Private Limited and 5 more | Additional Director | 10 Oct 2021 | 5 Years 0 Months | Current |
| Motilal Chawla Also directs: Almo Exports Private Limited, Radom Biosciences Private Limited, Amc Healthcare Private Limited and 2 more | Director | 01 May 2023 | 3 Years 5 Months | Current |
| Ashish Kumar Singh Also directs: Anekant Developers Private Limited, Axis Ups Private Limited., VKG Estates Private Limited and 3 more | Director | 31 Jul 2020 | 6 Years 2 Months | Current |
| Anil Kumar Also directs: Almo Impex (India) Private Limited, Almo Exports Private Limited, Scarlet Formulation Private Limited and 5 more | Director | 01 May 2023 | 3 Years 5 Months | Current |
Peer comparison
Anekant Pharmaceuticals Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Jivandhara Pharma Private Limited | ₹30.05 Cr (FY 2024) | 15.0% | Bilimora, Gujarat, India | |||
| Steranco Healthcare Private Limited | ₹29.92 Cr (FY 2025) | 121.0% | Mumbai, Maharashtra, India | |||
| Anekant Pharmaceuticals Private Limitedthis company | ₹29.83 Cr (FY 2021) | ₹7.13 Lakh | 0.2% | 54.0% | Delhi, India | |
| Usan Pharmaceuticals Private Limited | ₹29.79 Cr (FY 2025) | -7.0% | Mumbai, Maharashtra, India | |||
| Nemus Pharmaceuticals Private Limited | ₹29.76 Cr (FY 2025) | 21.0% | Kahalapur, Maharashtra, India | |||
| Vrnda Pharma Private Limited | ₹29.73 Cr (FY 2025) | 164.0% | Mumbai, Maharashtra, India | |||
| Cedric Pharmaceuticals Private Limited | ₹29.69 Cr (FY 2025) | 15.0% | Delhi, India |
To see the full peer comparison of Anekant Pharmaceuticals Private Limited, buy the company report.
Auditor
Anekant Pharmaceuticals Private Limited is audited by Bhawana Tiwari & Associates for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Bhawana Tiwari & Associates | FY 2021 | 032674N |
Shareholding
The shareholding of Anekant Pharmaceuticals Private Limited is on record for 4 financial years, the latest being FY 2021, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Anekant Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹1.1 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 03 Feb 2021 | 100413520 | Others | ₹1.1 Cr | Open |
Total charge records: 1 View all charges
Legal cases
Anekant Pharmaceuticals Private Limited has 1 court case on record: 1 filed against it. All case is pending.
Total cases
1
Filed against the company
1
Pending
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Central, Delhi | Cheque dishonour complaint | Filed against the company by Narang Biotec Pvt. Ltd. | Pending |
To see the full case history of Anekant Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Anekant Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Anekant Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAYCS1829C1ZZ | Uttar Pradesh | Active | 04 Dec 2018 |
To see the full GST registrations and return filing status of Anekant Pharmaceuticals Private Limited, buy the company report.
Recent activity
Anekant Pharmaceuticals Private Limited has 14 board changes on record since 2018: 5 appointments and 9 cessations. The latest: Amit Rastogi ceased to be Additional Director on 02 May 2023.
Ceased
Amit Rastogi ceased to be Additional Director.
Appointed
Anil Kumar was appointed as Director.
Appointed
Motilal Chawla was appointed as Director.
Ceased
Anju Rastogi ceased to be Additional Director.
AGM
Anekant Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Nov 2021 as per latest MCA records.
Appointed
Pankaj Jain was appointed as Additional Director.
Ceased
Sangeet Agrawal ceased to be Director.
Ceased
Jai Krishan Aggarwal ceased to be Director.
Filing
Anekant Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Delhi.
Charges
A charge with Others amounted to Rs. 110.00 Lakh with Charge ID 100413520 was registered on 03 Feb 2021.
Ceased
Sheenu Rastogi ceased to be Director.
Ceased
Akash Kaushik ceased to be Additional Director.
6 earlier events are in the company report.
Frequently asked questions
Anekant Pharmaceuticals is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 06 February 2017 (9+ years old) and is registered under CIN U36100DL2017PTC311457.
Anekant Pharmaceuticals has 5 current directors:
- Jai Krishan Aggarwal - Director
- Pankaj Jain - Additional Director
- Motilal Chawla - Director
- Ashish Kumar Singh - Director
- Anil Kumar - Director
The latest financial statements of Anekant Pharmaceuticals on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 30 November 2021. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Anekant Pharmaceuticals is 09AAYCS1829C1ZZ, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Anekant Pharmaceuticals is U36100DL2017PTC311457. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Anekant Pharmaceuticals has 1 court case on record: 1 filed against it. 1 is pending.
Anekant Pharmaceuticals was incorporated on 06 February 2017, making it 9+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Anekant Pharmaceuticals by revenue are Jivandhara Pharma Private Limited, Steranco Healthcare Private Limited, Usan Pharmaceuticals Private Limited, Nemus Pharmaceuticals Private Limited, Vrnda Pharma Private Limited and 1 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Amit Rastogi ceased to be Additional Director on 02 May 2023. Anil Kumar was appointed as Director on 01 May 2023. Motilal Chawla was appointed as Director on 01 May 2023. Anekant Pharmaceuticals has 14 board changes on record in total.
Yes, Anekant Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Anekant Pharmaceuticals can be reached through the website anekantpharma.com. Its registered office is in Delhi, India.